The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


2000 International Unit Pdr+Solv for Soln for Inj

Bayer AGEU/1/15/1077/004

Main Information

Trade NameIBLIAS
Active SubstancesOCTOCOG ALFA
Strength2000 International Unit
Dosage FormPdr+Solv for Soln for Inj
Licence HolderBayer AG
Licence NumberEU/1/15/1077/004

Group Information

ATC CodeB02BD02 coagulation factor VIII


Licence Issued18/02/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back